A subsequent study revealed that in breast cancer cell lines, the overexpression of HSF1 induced an augmentation of the cancer stem cell markers and conferred resistance to chemotherapeutic drugs (Wang et al., 2015). Here, HSF1 is linked to breast carcinoma.